Navigation Links
Echo Therapeutics Receives Funding and Commitment of Approximately $5.5 Million
Date:1/6/2011

year ended December 31, 2009, its quarterly reports on Form 10-Q, and its current reports on Form 8-K. Echo undertakes no obligation to publicly update or revise any forward-looking statements.For More Information:Patrick T. Mooney, M.D.

Media: Richard SternChairman and Chief Executive Officer

Stern & Co.(508) 530-0329

(212) 888-0044
'/>"/>

SOURCE Echo Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Alpha-1 Foundation Awards Two Research Grants with Support from Talecris Biotherapeutics, Inc.
2. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at the 29th Annual J.P. Morgan Healthcare Conference in San Francisco, CA
3. Amicus Therapeutics to Present at the 29th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2011
4. Halozyme Therapeutics to Present at J.P. Morgan Healthcare Conference on January 12
5. Karyopharm Therapeutics Inc. Appoints Michael Kauffman, MD, PhD, as Chief Executive Officer
6. Intarcia Therapeutics Executive Chairman Kurt Graves to Present at 29th Annual JP Morgan Healthcare Conference
7. Vicus Therapeutics Announces Initiation of Phase 2 Trial to Evaluate VT-122 in Patients with Liver Cancer Receiving Nexavar
8. King Pharmaceuticals and Pain Therapeutics Announce Resubmission of New Drug Application for REMOXY®
9. PTC Therapeutics Completes Enrollment of Phase 3 Trial of Ataluren in Patients with Cystic Fibrosis
10. Silence Therapeutics Provides Year-end Update
11. Angelica Therapeutics Receives a $244,479 Qualified Therapeutic Discovery Project Grant for Its Anti-Cancer Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... -- Research and Markets has announced the ... & Pipeline Insight 2014" report to their offering. ... and eradicate the prevalence of cancer have achieved limited ... low specificity, safety and large number of side effects, ... solution. It has been discovered that peptides can be ...
(Date:8/29/2014)... 29, 2014 Does your doctor know what you,re ... have recommended marijuana to the over 112,000 currently registered patients ... majority of the other roughly 20,300+ active physicians listed with ... about it – even though a poll in February 2014 ... they have tried it. "With marijuana legalization ...
(Date:8/29/2014)... Aug. 29, 2014   Vittamed Corporation , a neurodiagnostics ... announced today that T. (Teo) Forcht Dagi , MD, ... Board of Directors. " Teo Forcht Dagi ... neurosurgery, medical innovation and venture capital," said Remis Bistras ... to add his clinical, strategic, and entrepreneurial expertise to our ...
Breaking Medicine Technology:Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 3Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 4Vittamed Adds Prominent Neurosurgeon and Venture Capitalist T. Forcht Dagi to Board of Directors 2
... Chimerix, Inc., a biotechnology company developing orally-available antiviral ... data for CMX001 in a late-breaker presentation at ... and Chemotherapy (ICAAC, Chicago – September 17-20).   ... Infectious Diseases Service at Memorial Sloan-Kettering Cancer Center ...
... YORK, Sept. 16, 2011 MDC Partners ( ... a majority stake in leading healthcare and pharma ... ( www.concentricpharma.com ).  The partnership with Concentric marks ... growing healthcare marketing sector and positions MDC to ...
Cached Medicine Technology:Chimerix Announces Late-Breaker Presentation at 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Annual Meeting 2Chimerix Announces Late-Breaker Presentation at 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) Annual Meeting 3MDC Partners Launches Integrated Healthcare Marketing Platform With Acquisition of Majority Stake in Concentric Pharma Advertising 2
(Date:8/29/2014)... August 30, 2014 Market Research ... 2009-2019 is a professional and in-depth market survey ... report firstly reviews the basic information of Glass ... The report then explores global and China’s top ... capacity, Production value, and market share etc. , ...
(Date:8/29/2014)... Healthpointe is proud to welcome to its ... be practicing out of Healthpointe’s newest office directly adjacent ... orthopedic team, Dr. Rodas is board-certified in ... occupational medicine. , Among Dr. Rodas’ many impressive ... Raytheon, the world-class defense and aerospace company. Additionally, Dr. ...
(Date:8/29/2014)... Dr. Parsa Mohebi M.D. has developed new ... achieve great results in hair transplantation. One of these ... an FUE method that harvests facial hair for transplanting to ... patients whose hair loss classification is 5 and above achieve ... great alternative for those advanced hair loss patients who may ...
(Date:8/29/2014)... California (PRWEB) August 29, 2014 ... to Chapman University Physical Therapy students via Clinical ... Chapman University will be shadowing Healthpointe providers and ... allow them to develop clinical experience and learn ... Therapy students will gain insight into several patient ...
(Date:8/29/2014)... (HealthDay News) -- Astronauts may be at heightened ... human immune systems, a new study suggests. That ... to asteroids, the moon and Mars undertaken in the ... space can be dangerous, NASA researchers say. They ... blood of International Space Station crew members remains relatively ...
Breaking Medicine News(10 mins):Health News:Global and Chinese Glass Microfiber Industry Forecasts to 2019 in New Research Report Available at ReportsnReports.com 2Health News:Global and Chinese Glass Microfiber Industry Forecasts to 2019 in New Research Report Available at ReportsnReports.com 3Health News:Global and Chinese Glass Microfiber Industry Forecasts to 2019 in New Research Report Available at ReportsnReports.com 4Health News:Dr. Anthony G. Rodas Joins Healthpointe Team at LAX Office 2Health News:Advanced Hair Loss Patients Can Now Qualify for Hair Transplants Using Facial Donor Hair 2Health News:Healthpointe is Now Offering Clinical Rotations for Chapman University Physical Therapy Students 2Health News:Spaceflight Might Weaken Astronauts' Immune Systems 2
... As part of its ongoing commitment to keeping ... recognized leader in innovative healthcare administration for over 20 ... new full-service pharmacy benefit management (PBM) program, MagnaCareRx. ... pharmacy benefit management. With costs rising, plan sponsors can,t ...
... findings , TUESDAY, July 7 (HealthDay News) -- Parents ... that show a reduced-dose schedule for the pneumococcal vaccine ... The current recommended dose schedule for 7-valent pneumococcal conjugate ... age of 6 months, followed by a booster vaccination ...
... linked in studies to lower incidence of type 2 diabetes ... of a protein created by fat cells are associated with ... protein, adiponectin, appears to have anti-inflammatory and insulin-sensitizing capabilities, according ... the Journal of the American Medical Association . , ...
... Ulrich Stroeher, Chairman of the Advisory,Board of Berlin Heart, today ... the company on 30 September 2009. , ... one of the,intellectual fathers of the successful ventricular assist device ... this area as,coordinator for projects with external cooperation partners. He ...
... , ATLANTA, July 7 Crawford Canada,s Bill Johnstone ... Company,s (NYSE: CRDA ; CRDB) Global Technical ... designed to more effectively coordinate and grow this market-leading ... is a major differentiator for Crawford worldwide in the ...
... ... ... roving weather star, Al Roker, has packed up his Penske truck once again to hit ... consecutive year, "Lend a Hand" continues its mission to help small charities across the country ...
Cached Medicine News:Health News:MagnaCare Answers Need for New Prescription Drug Program 2Health News:Fewer Shots Could Still Protect Kids From Pneumonia 2Health News:Fat-Cell Protein May Reduce Diabetes Risk 2Health News:Fat-Cell Protein May Reduce Diabetes Risk 3Health News:Berlin Heart Announces Restructuring of Management 2Health News:Bill Johnstone Named Senior Vice President of Crawford's Global Technical Services for the Americas 2Health News:Supergoop! Award-Winning SPF 30 Sunscreen & Skin Protection Lotion Featured On The Today Show 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: